Silverarc Capital Management LLC Acquires New Position in Pieris Pharmaceuticals, Inc (NASDAQ:PIRS) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note released on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Up 2.1 % NASDAQ PIRS opened at $0.20 on Thursday. The stock has a market capitalization of $19.42 million, a P/E ratio […]
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS – Get Free Report) was the recipient of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 67,900 shares, a decline of 63.5% from the October 31st total of 186,100 shares. Based on an average trading volume of 1,070,000 shares, […]
Pieris Pharmaceuticals (NASDAQ:PIRS) Now Covered by StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research report sent to investors on Monday. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance PIRS opened at $0.23 on Monday. The firm’s 50-day simple moving average is $0.28 and its 200-day simple moving […]